Interim Analysis of the REASSURE (Radium-223 Alpha Emitter Agent in Non-Intervention Safety Study in mCRPC popUlation for Long-teRm Evaluation) Study: Patient Characteristics and Safety According to Prior Use of Chemotherapy in Routine Clinical Practice

European Journal of Nuclear Medicine and Molecular Imaging - Germany
doi 10.1007/s00259-019-4261-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Alpha-Emitter Radium-223 in the Management of Solid Tumors: Current Status and Future Directions

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2014English

Communication and Patient Safety in Gynecology and Obstetrics - Study Protocol of an Intervention Study

BMC Health Services Research
Health Policy
2019English

Tofacitinib: Efficiency and Safety in Long-Term Use

Medical Council
2019English

Walking, Quality of Life, and Safety With Prolonged-Release Fampridine Treatment in Clinical Practice: Interim Results of the Liberate Study

Journal of the Neurological Sciences
Neurology
2015English

Efficacy, Safety and the Routine Use of First Generation SADs in Paediatric Practice

Anaesthesia
AnesthesiologyPain Medicine
2017English

Long-Term Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing’s Disease: Interim Results From a Long-Term Real-World Evidence Study

Pituitary
EndocrinologyMetabolismDiabetes
2019English

Safety and Effectiveness of Sorafenib in Japanese Patients With Hepatocellular Carcinoma in Daily Medical Practice: Interim Analysis of a Prospective Postmarketing All-Patient Surveillance Study

Journal of Gastroenterology
Gastroenterology
2016English

Long-Term Safety Study of Infliximab in Moderate-To-Severe Chronic Obstructive Pulmonary Disease

Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Patient Safety in the Operating Room: An Intervention Study on Latent Risk Factors

BMC Surgery
MedicineSurgery
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy